Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer

BACKGROUND: Bone metastasis and skeletal related events (SREs) are common in non-small cell lung cancer (NSCLC). Patients with mutant epidermal growth factor receptor (EGFR) could benefit from tyrosine kinase inhibitors (TKIs). However, it is unclear whether SRE is influenced by EGFR status. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shu-Mei, Yang, Jin-Ji, Chen, Hua-Jun, Wu, Si-Pei, Bai, Xiao-Yan, Zhou, Qing, Tu, Hai-Yan, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655291/
https://www.ncbi.nlm.nih.gov/pubmed/29113396
http://dx.doi.org/10.18632/oncotarget.18759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655291/
https://www.ncbi.nlm.nih.gov/pubmed/29113396
http://dx.doi.org/10.18632/oncotarget.18759

Ejemplares similares